Studies toward the large-scale synthesis of the HIV proteinase inhibitor Ro 31-8959

…, DJ Bushnell, PH Crackett, SJ Dunsdon…

Index: Parkes, Kevin E. B.; Bushnell, David J.; Crackett, Peter H.; Dunsdon, Stephen J.; Freeman, Andrew C.; et al. Journal of Organic Chemistry, 1994 , vol. 59, # 13 p. 3656 - 3664

Full Text: HTML

Citation Number: 124

Abstract

Ro 31-8959 (11, a potent and selective inhibitor of HIV proteinase, is currently in phase I11 clinical trials. Six approaches for the large-scale synthesis of this compound have been studied. All routes employ an initial disconnection to an electrophilic L-phenylalanine homologue equivalent 13 and the decahydroisoquinoline derivative 5. They differ in adopting either an epoxide, a cyclic sulfate, or an aldehyde as the electrophilic entity and ...

Related Articles:

Reduction of peptide character of HIV protease inhibitors that exhibit nanomolar potency against multidrug resistant HIV-1 strains

[Journal of Medicinal Chemistry, , vol. 46, # 9 p. 1764 - 1768]

Studies toward the large-scale synthesis of the HIV proteinase inhibitor Ro 31-8959

[Journal of Organic Chemistry, , vol. 59, # 13 p. 3656 - 3664]

The development of cyclic sulfolanes as novel and high-affinity P2 ligands for HIV-1 protease inhibitors

[Journal of Medicinal Chemistry, , vol. 37, # 8 p. 1177 - 1188]

Reduction of peptide character of HIV protease inhibitors that exhibit nanomolar potency against multidrug resistant HIV-1 strains

[Journal of Medicinal Chemistry, , vol. 46, # 9 p. 1764 - 1768]

Development of a new type of protease inhibitors, efficacious against FIV and HIV variants

[Journal of the American Chemical Society, , vol. 121, # 6 p. 1145 - 1155]

More Articles...